1105 related articles for article (PubMed ID: 19782780)
81. Acceleration of spinal fusion using COMP-angiopoietin 1 with allografting in a rat model.
Park BH; Song KJ; Yoon SJ; Park HS; Jang KY; Zhou L; Lee SY; Lee KB; Kim JR
Bone; 2011 Sep; 49(3):447-54. PubMed ID: 21658484
[TBL] [Abstract][Full Text] [Related]
82. Reduction of protein phosphatase 2A Cα enhances bone formation and osteoblast differentiation through the expression of bone-specific transcription factor Osterix.
Okamura H; Yoshida K; Ochiai K; Haneji T
Bone; 2011 Sep; 49(3):368-75. PubMed ID: 21683816
[TBL] [Abstract][Full Text] [Related]
83. TGF-β/BMP signaling pathway is involved in cerium-promoted osteogenic differentiation of mesenchymal stem cells.
Liu DD; Zhang JC; Zhang Q; Wang SX; Yang MS
J Cell Biochem; 2013 May; 114(5):1105-14. PubMed ID: 23150386
[TBL] [Abstract][Full Text] [Related]
84. ER stress-inducible ATF3 suppresses BMP2-induced ALP expression and activation in MC3T3-E1 cells.
Park JK; Jang H; Hwang S; Kim EJ; Kim DE; Oh KB; Kwon DJ; Koh JT; Kimura K; Inoue H; Jang WG; Lee JW
Biochem Biophys Res Commun; 2014 Jan; 443(1):333-8. PubMed ID: 24315873
[TBL] [Abstract][Full Text] [Related]
85. Synergistic actions of insulin-sensitive and Sirt1-mediated pathways in the differentiation of mouse embryonic stem cells to osteoblast.
Srivastava S; Bedi U; Roy P
Mol Cell Endocrinol; 2012 Sep; 361(1-2):153-64. PubMed ID: 22542761
[TBL] [Abstract][Full Text] [Related]
86. Adenosine receptor subtype expression and activation influence the differentiation of mesenchymal stem cells to osteoblasts and adipocytes.
Gharibi B; Abraham AA; Ham J; Evans BA
J Bone Miner Res; 2011 Sep; 26(9):2112-24. PubMed ID: 21590734
[TBL] [Abstract][Full Text] [Related]
87. Melatonin rescues glucocorticoid-induced inhibition of osteoblast differentiation in MC3T3-E1 cells via the PI3K/AKT and BMP/Smad signalling pathways.
Zhao R; Tao L; Qiu S; Shen L; Tian Y; Gong Z; Tao ZB; Zhu Y
Life Sci; 2020 Sep; 257():118044. PubMed ID: 32622944
[TBL] [Abstract][Full Text] [Related]
88. BMP2 and VEGF promote angiogenesis but retard terminal differentiation of osteoblasts in bone regeneration by up-regulating Id1.
Song X; Liu S; Qu X; Hu Y; Zhang X; Wang T; Wei F
Acta Biochim Biophys Sin (Shanghai); 2011 Oct; 43(10):796-804. PubMed ID: 21880603
[TBL] [Abstract][Full Text] [Related]
89. High dose 1,25(OH)2D3 inhibits osteoblast mineralization in vitro.
Yamaguchi M; Weitzmann MN
Int J Mol Med; 2012 May; 29(5):934-8. PubMed ID: 22307202
[TBL] [Abstract][Full Text] [Related]
90. Curcumin induces osteoblast differentiation through mild-endoplasmic reticulum stress-mediated such as BMP2 on osteoblast cells.
Son HE; Kim EJ; Jang WG
Life Sci; 2018 Jan; 193():34-39. PubMed ID: 29223538
[TBL] [Abstract][Full Text] [Related]
91. BMP2 differentially regulates the expression of Gremlin1 and Gremlin2, the negative regulators of BMP function, during osteoblast differentiation.
Suzuki D; Yamada A; Aizawa R; Funato S; Matsumoto T; Suzuki W; Takami M; Miyamoto Y; Suzawa T; Yamamoto M; Baba K; Kamijo R
Calcif Tissue Int; 2012 Jul; 91(1):88-96. PubMed ID: 22644325
[TBL] [Abstract][Full Text] [Related]
92. Geranylgeranyl pyrophosphate stimulates PPARγ expression and adipogenesis through the inhibition of osteoblast differentiation.
Weivoda MM; Hohl RJ
Bone; 2012 Feb; 50(2):467-76. PubMed ID: 22019459
[TBL] [Abstract][Full Text] [Related]
93. A peptide that blocks the interaction of NF-κB p65 subunit with Smad4 enhances BMP2-induced osteogenesis.
Urata M; Kokabu S; Matsubara T; Sugiyama G; Nakatomi C; Takeuchi H; Hirata-Tsuchiya S; Aoki K; Tamura Y; Moriyama Y; Ayukawa Y; Matsuda M; Zhang M; Koyano K; Kitamura C; Jimi E
J Cell Physiol; 2018 Sep; 233(9):7356-7366. PubMed ID: 29663368
[TBL] [Abstract][Full Text] [Related]
94. c-Jun N-terminal kinase 1 negatively regulates osteoblastic differentiation induced by BMP2 via phosphorylation of Runx2 at Ser104.
Huang YF; Lin JJ; Lin CH; Su Y; Hung SC
J Bone Miner Res; 2012 May; 27(5):1093-105. PubMed ID: 22247071
[TBL] [Abstract][Full Text] [Related]
95. In vitro response of primary human bone marrow stromal cells to recombinant human bone morphogenic protein-2 in the early and late stages of osteoblast differentiation.
Kim IS; Song YM; Cho TH; Park YD; Lee KB; Noh I; Weber F; Hwang SJ
Dev Growth Differ; 2008 Sep; 50(7):553-64. PubMed ID: 19238726
[TBL] [Abstract][Full Text] [Related]
96. HtrA1 is upregulated during RANKL-induced osteoclastogenesis, and negatively regulates osteoblast differentiation and BMP2-induced Smad1/5/8, ERK and p38 phosphorylation.
Wu X; Chim SM; Kuek V; Lim BS; Chow ST; Zhao J; Yang S; Rosen V; Tickner J; Xu J
FEBS Lett; 2014 Jan; 588(1):143-50. PubMed ID: 24269886
[TBL] [Abstract][Full Text] [Related]
97. Optimizing the osteogenic differentiation of human mesenchymal stromal cells by the synergistic action of growth factors.
Açil Y; Ghoniem AA; Wiltfang J; Gierloff M
J Craniomaxillofac Surg; 2014 Dec; 42(8):2002-9. PubMed ID: 25458345
[TBL] [Abstract][Full Text] [Related]
98. Blockade of airway inflammation and hyper-responsiveness by an angiopoietin-1 variant, COMP-Ang1.
Lee KS; Lee KY; Kim SR; Park HS; Park SJ; Min KH; Cho CH; Koh GY; Park HS; Lee YC
Exp Mol Med; 2007 Dec; 39(6):733-45. PubMed ID: 18160844
[TBL] [Abstract][Full Text] [Related]
99. Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A.
Deckers MM; van Bezooijen RL; van der Horst G; Hoogendam J; van Der Bent C; Papapoulos SE; Löwik CW
Endocrinology; 2002 Apr; 143(4):1545-53. PubMed ID: 11897714
[TBL] [Abstract][Full Text] [Related]
100. COMP-Ang1, a variant of angiopoietin 1, inhibits serum-deprived apoptosis of mesenchymal cells via PI3K/Akt and mitogen-activated protein kinase pathways.
Lee KN; Seo MC; Bae IH; Oh SH; Jang WG; Jeong BC; Oh WM; Kim SH; Lee SE; Shim KM; Park BK; Koh JT
Pharmacology; 2010; 86(5-6):327-35. PubMed ID: 21109762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
